一个生物模拟多功能纳米平台,具有精确的准透和高效的协同疗法,用于缺血性中风
Xi-Sheng Li1, Hui-Yin Li1, Dan Peng1
1Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P. R. China.
ACS applied materials & interfaces
|July 4, 2025
概括
一个新的纳米平台通过穿越血脑屏障来准缺血性中风,减少炎症和氧化应激. 这种方法增强了神经元的再生,并改善了中风模型中的认知功能.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 神经科学是一个神经科学.
背景情况:
- 缺血性中风的治疗受血脑屏障和复杂的病理生理学限制.
- 氧化应激和神经炎症是中风引起的大脑损伤的关键因素.
研究的目的:
- 开发一个针对性缺血性中风治疗的多功能纳米平台.
- 为了克服血脑屏障的局限性,并解决多因素中风病理生理学.
主要方法:
- 使用金属有机框架 (Zn-DB) 构建了一个仿生纳米平台 (RH@CZB-D-A),用CeO2纳米颗粒装饰,装载了deferoxamine和anti-C5a的aptamer,并用类似中性粒细胞的膜进行伪装.
- 利用RVG29进行血脑屏障透和免疫逃避.
- 在酸性病变中研究了针对药物释放的pH-酸性反应.
- 评估了纳米平台对微质偏振,神经炎症,氧化应激和神经元存活的 in vitro 和 in vivo 模型的影响.
主要成果:
- 该纳米平台成功穿透了血脑屏障,并针对缺血性病变.
- RH@CZB-D-A有效地清除了反应性氧物种,减少了神经炎症和减轻了氧化应激.
- 通过抗氧化,抗亡,抗铁亡和抗炎症来证明协同的神经保护.
- 在MCAO小鼠模型中,纳米平台促进了神经元再生,改善了神经系统缺陷,增强了空间记忆和学习.
结论:
- 开发的仿生纳米平台为缺血性中风治疗提供了一个有前途的战略.
- 由于其有针对性的输送和多机制的治疗效果,RH@CZB-D-A具有临床应用的潜力.
- 这种方法为改善缺血性中风患者的治疗结果提供了一个替代的治疗途径.
相关概念视频
Ischemic Stroke l: Introduction
53
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68


